23 Results for "

lapatinib

" in MedChemExpress (MCE) Product Catalog:
Products (23)

23 Results for "lapatinib" in MCE Product Catalog:

95
95 Publications Verification
Cat. No.: HY-50898
CAS No.: 231277-92-2
Synonyms: GW572016; GW2016
Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
95
95 Publications Verification
Cat. No.: HY-50898A
CAS No.: 388082-77-7
Synonyms: GW572016 ditosylate; GW2016 ditosylate
Lapatinib ditosylate (GW572016 ditosylate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
95
95 Publications Verification
Cat. No.: HY-50898B
CAS No.: 388082-78-8
Synonyms: GW572016 ditosylate monohydrate; GW2016 ditosylate monohydrate
Target:  

EGFR Autophagy Ferroptosis

Research Areas:  

Infection Metabolic Disease Cancer

Lapatinib ditosylate monohydrate (GW572016 ditosylate monohydrate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-116437
CAS No.: 1275595-86-2
Purity:  99.83%
Target:  

EGFR

Research Areas:  

Cancer

Selatinib is an orally active EGFR and HER2 tyrosine kinase inhibitor with IC50 values of 13.0 nM and 8.5 nM, respectively. Selatinib undergoes oxidative metabolism in vivo to produce Lapatinib (HY-50898). Selatinib inhibits the growth of breast, gastric and ovarian tumors. Selatinib can be used in research related to gastric cancer, breast cancer and ovarian cancer .
loading...
    loading...
Cat. No.: HY-50898S4
CAS No.: 1009307-23-6
Synonyms: GW572016-d7; GW2016-d7
Lapatinib-d7 (GW572016-d7) is deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-P3498
CAS No.: 914009-84-0
Synonyms: ZP1846
Target:  

GCGR

Research Areas:  

Others

Elsiglutide (ZP1846) is a GLP-2 analogue, an orally active and selective GLP-2 receptor agonist, increases cell proliferation and reduces apoptosis in the intestine. Elsiglutide improves Lapatinib (HY-50898)-induced diarrhoea in rat model .
loading...
    loading...
Cat. No.: HY-172970
CAS No.: 3093763-71-1
Research Areas:  

Cancer

HQY1428 is an orally active CDK12 inhibitor. HQY1428 inhibits DNA replication, causes G2/M arrest in SKOV3 cells, induces DNA double-strand breaks and apoptosis. HQY1428 has anti-tumor activity in the SKOV3 xenograft mouse model. HQY1428 combined with the HER2 inhibitor Lapatinib (HY-50898) in the NCI-N87 xenograft mouse model produces a synergistic therapeutic effect .
loading...
    loading...
Cat. No.: HY-50898S1
Synonyms: GW572016-d7 dihydrochloride; GW2016-d7 dihydrochloride
Lapatinib-d7 dihydrochloride is the deuterium labeled Lapatinib dihydrochloride. Lapatinib (GW572016) dihydrochloride is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898S
CAS No.: 1184263-99-7
Synonyms: GW572016-d4; GW2016-d4
Lapatinib-d4 is the deuterium labeled Lapatinib (HY-50898). Lapatinib is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-P11197
CAS No.: 895547-36-1
Target:  

Gap Junction Protein

Research Areas:  

Cancer

ACT1 is a peptide that targets endogenous Cx43 by stabilizing its activity at gap junctions. ACT1 stabilizes gap junction intercellular communication in breast cancer cells. ACT1 enhances the activity of Tamoxifen (HY-13757A) and Lapatinib (HY-50898) in breast cancer. ACT1 can be used for breast cancer research .
loading...
    loading...
Cat. No.: HY-174414
Target:  

EGFR

Research Areas:  

Cancer

EGFR/HER2-IN-18 is a stable EGFR/HER2 dual inhibitor with IC50 values of 0.09 (EGFR) and 0.08 μM (HER2) respectively. EGFR/HER2-IN-18 exhibits broad-spectrum anti-cancer activity. EGFR/HER2-IN-18 induces MCF-7 cells apoptosis and inhibits the cell cycle. EGFR/HER2-IN-18 can be used for the study of breast cancer .
loading...
    loading...
Cat. No.: HY-50898R
CAS No.: 231277-92-2
Synonyms: GW572016 (Standard); GW2016 (Standard)
Research Areas:  

Cancer

Lapatinib (Standard) is the analytical standard of Lapatinib. This product is intended for research and analytical applications. Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-W777297
CAS No.: 1246819-08-8
Lapatinib- 13C2, 15N Ditosylate is the 13C- and 15N-labeled Lapatinib ditosylate (HY-50898A). Lapatinib ditosylate (GW572016 ditosylate) is a potent inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898AR
CAS No.: 388082-77-7
Synonyms: GW572016 ditosylate (Standard); GW2016 ditosylate (Standard)
Research Areas:  

Cancer

Lapatinib (ditosylate) (Standard) is the analytical standard of Lapatinib (ditosylate). This product is intended for research and analytical applications. Lapatinib ditosylate (GW572016 ditosylate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898BR
CAS No.: 388082-78-8
Synonyms: GW572016 ditosylate monohydrate (Standard); GW2016 ditosylate monohydrate (Standard)
Research Areas:  

Cancer

Lapatinib (ditosylate monohydrate) (Standard) is the analytical standard of Lapatinib (ditosylate monohydrate). This product is intended for research and analytical applications. Lapatinib ditosylate monohydrate (GW572016 ditosylate monohydrate) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898CS
CAS No.: 2749856-05-9
Synonyms: GW572016-d4 tosylate; GW2016-d4 tosylate
Lapatinib-d4 (GW572016-d4) tosylate is deuterium labeled Lapatinib (tosylate). Lapatinib (GW572016) tosylate is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-20390S
Lapatinib impurity 18-d4 is deuterium labeled 3-Chloro-4-((3-fluorobenzyl)oxy)aniline.
loading...
    loading...
Cat. No.: HY-50898S2
CAS No.: 2748212-14-6
Synonyms: GW572016-d5; GW2016-d5
Lapatinib-d5 is deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898C
CAS No.: 1187538-35-7
Synonyms: GW572016 tosylate; GW2016 tosylate
Target:  

EGFR Ferroptosis Autophagy

Research Areas:  

Cancer

Lapatinib (GW572016) tosylate is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...
Cat. No.: HY-50898S3
CAS No.: 1184264-15-0
Synonyms: GW572016-d4-1; GW2016-d4-1
Lapatinib-d4-1 is deuterium labeled Lapatinib. Lapatinib (GW572016) is a potent, orally active inhibitor of the ErbB-2 and EGFR tyrosine kinase domains with IC50 values against purified EGFR and ErbB-2 of 10.2 and 9.8 nM, respectively .
loading...
    loading...